Monday, June 17, 2019

Florida Board of Pharmacy Meetings

June 17, 2019 
Pharmacy Practice Committee 
Rosen Plaza Hotel
9700 International Dr.
Orlando, FL 32819

Get Directions →407-996-9700 
Materials:
FAR Notice (PDF)
Agenda (PDF) 
Public Book
 (PDF)
June 17, 2019 
Compounding Committee Meeting 
Rosen Plaza Hotel
9700 International Drive
Orlando, FL 32819

Get Directions →(407) 996-9700 
Materials:
FAR Notice (PDF)
Agenda (PDF) 
Public Book
 (PDF)
June 18 - June 19, 2019 
Board Meeting 
Rosen Plaza Hotel
9700 International Dr.
Orlando, FL 32819

Get Directions →
Materials:
FAR Notice (PDF)
Agenda (PDF) 
Public Book
 (PDF)
June 27, 2019 
Pharmacy Rules Subcommittee 
Telephone Conference Call @ 1:00 p.m. EST
Meet Me #: 1 (888) 585-9008
Participation Code: 599196982
Materials:

Oklahoma Board of Pharmacy Minutes from May 8, 2019 Meeting

May 8, 2019 Minutes

Louisiana Board of Pharmacy Legislative Proposals

Legislative Proposals


2019-C ~ Amends the Prescription Monitoring Program (PMP) Law to allow federal jurisdictions, electronic health record systems and pharmacy information systems to have access to the PMP database through the PMP Gateway service.
               01-16-2019 - Regulation Revision Committee voted to recommend the approval of Draft #1 to the Board.
               02-19-2019 - Draft #1 approved for filing by the Board.
               03-29-2019 - Incorporated in SB 53; prefiled for 2019 Regular Session.
               08-01-2019 - Effective date of Act 80 (SB 53).


2019-B ~ Amends the Controlled Substances Law, specifically the licensing section, to authorize the Board to require certain applicants for a state CDS license to submit to a criminal history record check as part of the licensing process.
               01-16-2019 - Regulation Revision Committee voted to recommend the approval of Draft #1 to the Board.
               02-19-2019 - Draft #1 approved for filing by the Board.
               03-29-2019 - Incorporated in HB 375; prefiled for 2019 Regular Session.
               08-01-2019 - Effective date of Act 219 (HB 375)
  

2019-A ~ Amends the Controlled Substances Law to add additional substances to Schedule I, consistent with DEA scheduling actions since the last legislative session.
               01-16-2019 - Regulation Revision Committee voted to recommend the approval of Draft #2 to the Board. 
               02-19-2019 - Board accepted technical amendments requested by the La. State Police, then approved Draft #3 for filing.
               03-29-2019 - Incorporated in HB 138; prefiled for 2019 Regular Session.

Louisiana Board of Pharmacy Regulatory Projects

Regulatory Projects


2019-1A ~ Marijuana Pharmacies [Source: Regulatory Proposal 2019-B]
               04-10-2019     1st Report submitted to Joint Legislative Oversight Committee on Health & Welfare.
               04-10-2019     Distributed electronic Notice of Rulemaking Activity to List of Interested Parties, as well as all pharmacies, pharmacists, pharmacy interns, pharmacy technicians, and pharmacy technician canddates.
               04-20-2019     Notice of Intent published in Louisiana Register.
               05-29-2019     Public Hearing


2018-3 ~ Drugs of Concern - Naloxone [Source: Regulatory Proposal 2018-E]
               09-10-2018     1st Report submitted to Joint Legislative Oversight Committee on Health and Welfare.
               09-10-2018     Distributed electronic Notice of Rulemaking Activity to List of Interested Parties, as well as all pharmacies, pharmacists, pharmacy interns, pharmacy technicians, and pharmacy technician candidates.
               09-20-2018     Notice of Intent scheduled for publication in Louisiana Register.
               10-26-2018     Public Hearing
               12-03-2018     2nd Report submitted to Joint Legislative Oversight Committee on Health & Welfare.
               12-03-2018     Distributed electronic Notice of Rulemaking Activity to List of Interested Parties, as well as all pharmacies, pharmacists, pharmacy interns, pharmacy technicians, and pharmacy technician candidates.
               01-20-2019     Final Rule published in Louisiana Register, effective today.
               02-26-2019     3rd Report - completion of regulatory report

Louisiana Board of Pharmacy Regulatory Proposals

Regulatory Proposals

2019-D
 ~ Amends §2919 of the Board's rules to provide for automatic registration of pharmacists for access privileges to query the state prescription monitoring program.
               03-19-2019 - Committee voted to recommend the approval of Draft #1 to the Board.
               05-29-2019 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.


2019-C 
~ Amends the chapter of rules for automated medication systems to authorize placement of such devices in detention and correctional facilities, and makes other technical corrections.
               03-19-2019 - Draft #1 on agenda for review by Regulation Revision Committee; not considered.
               04-24-2019 - Committee requested amendments, resulting in Draft #2.  Subsequent to the meeting, the Board President authorized the transfer of a portion of the contents from Regulatory Proposal 2019-A re Pharmacy Records referencing Chapter 12 - Automated Medication Systems to this proposal, to keep all the related contents in the same proposal.  The resulting document is Draft #3.  
               06-13-2019 - Draft #3 on agenda for review by Regulation Review Committee.  


2019-B
 ~ Amends the marijuana pharmacy rules (Subchapter E of Chapter 24) to repeal the limitations on the amount of THC per dose and per package, revise the limitations on advertising, permit the receipt of facsimile recommendation forms in marijuana pharmacies, and require inspection of premises prior to issuing permits.
               01-16-2019 - Committee vote to recommend the approval of Draft #2 to the Board.
               02-19-2019 - Board voted to approve Draft #2 for promulgation, upon the instruction of the President.
               
03-20-2019 - Occupational Licensing Review Commission determined that Sections 2441, 2443, and 2457 could be promulgated without Commission Review; however Section 2447 required Commission review prior to promulgation.
               04-20-2019 - Sections 2441, 2443, and 2457 incorporated as Regulatory Project 2019-1A.
               04-20-2019 - Section 2447 incorporated as Regulatory Project 2019-1B.


2019-A 
~ Amends multiple chapters of rules to implement Act 602 of the 2018 Legislature, which recognizes the use of chart orders by pharmacies serving patients in institutional healthcare facilities.
               11-07-2018 - Members reviewed stakeholder input and requested a first draft for its next committee meeting.
               01-16-2019 - Committee reviewed, in part, Draft #1; will continue their review at their next meeting.
               03-19-2019 - Members completed their review of Draft #1, made changes, and requested a new draft.
               04-24-2019 - Committee voted to recommend the approval of Draft #2 by the Board.  Subsequent to the committee meeting, the Board President authorized the removal of the portion of Draft #2 referencing Chapter 12 - Automated Medication Systems and transferred that content to Regulatory Proposal 2019-C (see above) relative to automated medication systems, to place all that related text within the same proposal.  The resulting document is Draft #3.
               05-29-2019 - Board voted to approve Draft #3 for promulgation, upon the instruction of the President.

Recent and Future Action by the Louisiana Board of Pharmacy


06-26-2019     Public Hearing

06-13-2019     Regulation Revision Committee   (revised 06-10)

06-12-2019     USP-800 Subcommittee

05-30-2019     Administrative Hearing   (revised 05-20)

05-29-2019     Board Meeting                    Public Meeting Binder

When will the United States start investigating how many compounding pharmacies are violating international laws, treaties and trade agreements by supplying foreign countries with compounded drugs?

Iowa Board of Pharmacy

California Board of Pharmacy Accusations filed

Advance Medical Pharmacy, PHY 54381, Administrative Case AC 6495
Walnut Creek, CA
Accusation Filed 4/5/2019; Case pending.
Partner Healthcare Inc., PHY 51078, Administrative Case AC 6176
Monrovia, CA
Third Amended Accusation Filed 4/15/2019; Case pending.
Partner Healthcare Inc., LSC 99777, Administrative Case AC 6176
Monrovia, CA
Third Amended Accusation Filed 4/15/2019; Case pending.
Saint Thomas Pharmacy, PHY 51456, Administrative Case AC 6480
Long Beach, CA
Accusation Filed 4/30/2019; Case pending.
Senior Care Pharmacy, LSC 99060, Administrative Case AC 6175
Garden Grove, CA
Accusation Filed 4/25/2019; Case pending.
Senior Care Pharmacy, Applicant, Statement of Issues Case AC 6409
Garden Grove, CA
Statement of Issues Filed 4/25/2019; Case pending.
Senior Care Pharmacy Services Inc., PHY 46000, Administrative Case AC 6175
Garden Grove, CA
Accusation Filed 4/25/2019; Case pending.
Senior Care Pharmacy Services HB Inc., Applicant, Statement of Issues Case AC 6156
Huntington Beach, CA
Statement of Issues Filed 4/25/2019; Case pending.
Stanford Health Care, HSP 44847, Administrative Case AC 6631
Stanford, CA
Accusation Filed 4/30/2019; Case pending.
Stanford Health Care, LSC 100453, Administrative Case AC 6631
Stanford, CA
Accusation Filed 4/30/2019; Case pending.
The Druggist Inc., PHY 50146, Administrative Case AC 5321
Valencia, CA
Third Amended Accusation Filed 4/9/2019; Case pending.
Tropicana Drugs, PHY 17122, Administrative Case AC 6469
San Jose, CA
First Amended Accusation Filed 4/30/2019; Case pending.
Qualgen LLC, Applicant, Statement of Issues Case SI 6602
Edmond, OK
Statement of Issues Filed 4/30/2019; Case pending.
White Cross Pharmacy, PHY 39991, Administrative Case AC 6336
Brawley, CA
Accusation Filed 4/30/2019; Case pending.
Facility Licenses
Cardinal Health, WLS 3176, Administrative Case AC 5724
Valencia, CA
Through a disciplinary action of the Board, the license is revoked, the revocation is stayed, and the license is placed on probation for two years subject to the terms and conditions in the decision.
Decision effective 04/03/2019.
Ferry’s Pharmacy, PHY 19913, Administrative Case AC 5964
Anderson, CA
Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended.
Decision effective 05/15/2019.
Getwell Pharmacy & Medical Supply, PHY 50159, Administrative Case AC 5904
San Leandro, CA
Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended.
Decision effective 06/7/2019.
Kaiser Foundation Hospital Inpatient/Outpatient Pharmacy. HSP 6602, Administrative Case AC 6212
San Francisco, CA
Through a disciplinary action of the Board, the license is revoked, the revocation is stayed, and the license is placed on probation for six years subject to the terms and conditions in the decision.
Decision effective 05/15/2019.
KRS Global Biotechnology, NRP 1007, Administrative Case AC 6315
Boca Raton, FL
Through a disciplinary action of the Board, the license is voluntarily surrendered.
Decision effective 04/03/2019.
KRS Global Biotechnology, NSC 99554, Administrative Case AC 6315
Boca Raton, FL
Through a disciplinary action of the Board, the license is voluntarily surrendered.
Decision effective 04/03/2019.
Lane Medical Pharmacy Inc., PHY 53609, Administrative Case AC 6346
Los Angeles, CA
Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended.
Decision effective 04/03/2019.
Livingston, Stern & Associates, WLS 3576, Administrative Case AC 6142
Santa Monica, CA
Through a disciplinary action of the Board, the license is subject to public reproval.
Decision effective 05/29/2019.
Loma Linda Pharmacy Inc., PHY 44306, Administrative Case AC 5296
Loma Linda, CA
Through a disciplinary action of the Board, the license is publicly reproved.
Decision effective 04/03/2019.
Medallion Prescription Pharmacy, PHY 48673, Administrative Case AC 5838
West Hills, CA
Through a disciplinary action of the Board, the license is revoked, the revocation is stayed, and the license is placed on probation for three years subject to the terms and conditions in the decision.
Decision effective 05/02/2019.
New Age Pharmaceuticals, Inc., PHY 48626, Administrative Case AC 5252
Los Angeles, CA
Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended.
Decision effective 04/03/2019.
Omro Pharmacy, NRP 2090, Statement of Issues Case SI 6476
Omro, WI
Through a disciplinary action of the Board, the license granted and publicly reproved.
Decision effective 04/03/2019.
Park Compounding Inc., LSC 100771, Administrative Case AC 6271
Irvine, CA
Through a disciplinary action of the Board, the license is voluntarily surrendered. The effective date shall be stayed until August 27, 2019, at which time the pharmacy shall be sold or closed.
Decision effective 05/29/2019.
Riverside Discount Drugs, PHY 38122, Administrative Case AC 6274
North Hollywood, CA
Through a disciplinary action of the Board, the license is revoked, the revocation is stayed, and the license is placed on probation for four years subject to the terms and conditions in the decision.
Decision effective 05/02/2019.
Rx Plus Pharmacy, PHY 43153, Administrative Case AC 6146
Anaheim, CA
Through a disciplinary action of the Board, the license is voluntarily surrendered.
Decision effective 04/03/2019.
The Medicine Shoppe, PHY 47602, Administrative Case AC 6312
Marysville, CA
Through a disciplinary action of the Board, the license is publicly reproved.
Decision effective 05/02/2019.
The Medicine Shoppe Pharmacy, PHY 55616, Administrative Case AC 6312
Marysville, CA
Through a disciplinary action of the Board, the license is publicly reproved.
Decision effective 05/02/2019.
Yorba Linda Pharmacy, PHY 44045, Administrative Case AC 6273
Anaheim, CA
Through a disciplinary action of the Board, the license is revoked, the revocation is stayed, and the license is placed on probation for five years subject to the terms and conditions in the decision.
Decision effective 05/29/2019.

California Board of Pharmacy Meeting Agenda for June 21, 2019

June 21, 2019Keck Graduate Institute, School of Pharmacy
517 Watson Drive
Claremont, CA 91711
Founders Room #165
6/21/19
Agenda
   6/21/19
Webcast

Sunday, June 16, 2019

Wyoming Board of Pharmacy June 2019 Newsletter

West Virginia Board of Pharmacy June 2019 Newsletter

Tennessee Board of Pharmacy June 2019 Newsletter

North Dakota State Board of Pharmacy June 2019 Newsletter

New Mexico Board of Pharmacy June 2019 Newsletter

Missouri Board of Pharmacy June 2019 Newsletter

Maryland Board of Pharmacy 2019 Newsletter

Kentucky Board of Pharmacy June 2019 Newsletter

Kansas Board of Pharmacy June 2019 Newsletter

Iowa State Board of Pharmacy June 2019

Idaho State Board of Pharmacy June 2019 Newsletter

Friday, June 14, 2019

Coborn's Pharmacy to Pay $225000 Penalty for Employee Theft of ...

Twin Cities Business Magazine-5 hours ago
Earlier this week Minnesota U.S. Attorney Erica McDonald announced that St. Cloud-based Coborn's Inc., doing business as Coborn's Pharmacy, would pay ...

Pharmacy tech regs meant to increase safety

Colorado Springs Business Journal-3 hours ago
During her 12 years of teaching Pikes Peak Community College's aspiring pharmacytechnicians, Nicole Barriera has started every semester with the same

Florida pharmacy owner gets 6 year sentence for role in $2.2M fraud ...

Becker's Hospital Review-2 hours ago
The owner of a pain clinic and pharmacy in Florida was sentenced to more than six years in prison and three years probation for his role in a $2.2 million ...

State bill could lower prescription drug prices, keep local pharmacies ...

amNY-10 hours ago
With days left in the legislative session, state lawmakers are considering a bill that has the potential to save local pharmacies “from extinction,” according to the ...

Tulsa US Attorney: Three Docs, Five Marketers Charged In Health ...

Insurance News Net-8 hours ago
The men allegedly caused federal health care insurance programs to pay reimbursement costs for fraudulent and expensive compounding drug prescriptions 

DOJ: 3 physicians, 5 marketers charged for violations to federal anti ...

KTUL-18 hours ago
Compounding prescriptions is a practice where a pharmacist or physician combines ingredients of multiple drugs to create a medication that is modified to the ...

DOJ charges Oklahoma orthopedic surgeon, others in $4.3M ...

Becker's Orthopedic & Spine-3 hours ago
Gary Robert Lee, MD, and Christopher Parks were accused of bribing physicians to write compounding drug prescriptions for their patients. Orthopedic surgeon ..

Ex-pharmacist gets 2 years, $7 million bill for role in scheme to bilk ...

Task & Purpose-Jun 11, 2019
The duo ran CMG RX, a Dallas company that primarily marketed compounded pain and scar creams to current and former U.S. military members and their .

Doctor Involved in Compound Prescription Fraud Scheme Sentenced ...

Daily Voice-3 hours ago
According to U.S. Attorney John Durham, Advantage Pharmacy was a compounding pharmacy located in Hattiesburg, Mississippi. The specialty medication they ...

Letco Medical Supports FDA's Statement Regarding The Proper Use ...

PRNewswire (press release)-Jun 10, 2019
We applaud the work by the FDA to ensure patients have access to compoundedmedications, whether prepared with traditional active pharmaceutical ...

Hospitals Rely on FDA-Designated Outsourcing Facilities for ...

Regulatory Focus-Jun 12, 2019
Among US hospitals that obtained non-patient-specific (NPS) compounded drugs from outside compounders, 89% of hospitals obtained them only from ..

Areas to Focus on When Considering Sterile Compounding

Pharmacy Times-Jun 13, 2019
Patricia Kienle, BSPHARM, MPA, FASHP: I look at 3 different areas where sterile compounding has mixed. First of all, most of us have the IV rooms or IV labs

FDA is Committed to Sound, Science-based Policy on CBD

Science forms the basis for decisions at the U.S. Food and Drug Administration (FDA) and is paramount when it comes to making decisions that will impact the health and safety of the American public. We apply this rigorous, science-based approach to matters large and small that come before the Agency – including with respect to products containing cannabis or cannabis-derived compounds, including cannabidiol (CBD).

We recognize that there is significant public interest in these products, for therapeutic purposes and otherwise. At the same time, there are many unanswered questions about the science, safety, and quality of many of these products. As we approach these questions, we do so as a science-based regulatory agency committed to our mission of protecting and promoting public health.